Adults with type 2 diabetes and a moderate or high risk of CVD were less likely to experience a serious cardiovascular event ...
August 30, 2009 (Barcelona, Spain) — The use of low-dose aspirin in the primary prevention of cardiovascular events in healthy individuals with asymptomatic atherosclerosis is currently not warranted, ...
The use of aspirin for the primary prevention of cardiovascular events in patients with type 2 diabetes mellitus is controversial. According to the findings of a Japanese trial, aspirin does not ...
The role of aspirin in preventing a first heart attack or stroke among people at moderate risk of heart disease remains unclear. At the 2018 European Society of Cardiology meeting, J. Michael Gaziano, ...
People with type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a major cardiovascular event, including heart attack, ...
Researchers sought to examine the safety of aspirin as a primary prevention method for atherosclerotic cardiovascular events in high-risk patients. The use of aspirin as a primary prevention for ...
(HealthDay News) — There is more than a 30% increased risk of cardiovascular events following discontinuation of low-dose aspirin in long-term users, according to a study published in Circulation.
WASHINGTON—An influential federal panel issued final recommendations that men and women aged 50 to 69 consider taking low-dose aspirin if they are at high risk for heart attacks and strokes. The U.S.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Long-term use of hydroxychloroquine and ...
In an open-label, pragmatic trial, patients with cardiovascular disease were randomly assigned to a strategy of 81 mg or 325 mg of aspirin daily. A substantial proportion of those assigned to the ...
Recommendations on the use of low-dose aspirin for the primary prevention of cardiovascular disease in women are, in fact, based on data derived mainly from men. Recent results from the Women's Health ...